Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
145.10
+2.57 (1.80%)
At close: Sep 5, 2025, 4:00 PM
145.00
-0.10 (-0.07%)
After-hours: Sep 5, 2025, 7:50 PM EDT
Insmed Market Cap
Insmed has a market cap or net worth of $30.67 billion as of September 5, 2025. Its market cap has increased by 134.25% in one year.
Market Cap
30.67B
Enterprise Value
29.55B
1-Year Change
134.25%
Ranking
Category
Stock Price
$145.10
Market Cap Chart
Since June 1, 2000, Insmed's market cap has increased from $445.50M to $30.67B, an increase of 6,784.51%. That is a compound annual growth rate of 18.22%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 30.67B | 148.32% |
Dec 31, 2024 | 12.35B | 178.59% |
Dec 29, 2023 | 4.43B | 63.79% |
Dec 30, 2022 | 2.71B | -16.06% |
Dec 31, 2021 | 3.22B | -4.92% |
Dec 31, 2020 | 3.39B | 58.95% |
Dec 31, 2019 | 2.13B | 110.95% |
Dec 31, 2018 | 1.01B | -57.65% |
Dec 29, 2017 | 2.39B | 191.73% |
Dec 30, 2016 | 818.60M | -27.02% |
Dec 31, 2015 | 1.12B | 46.00% |
Dec 31, 2014 | 768.30M | 15.55% |
Dec 31, 2013 | 664.90M | 217.07% |
Dec 31, 2012 | 209.70M | 177.01% |
Dec 30, 2011 | 75.70M | -7.91% |
Dec 31, 2010 | 82.20M | -18.05% |
Dec 31, 2009 | 100.30M | 75.35% |
Dec 31, 2008 | 57.20M | -43.08% |
Dec 31, 2007 | 100.50M | 13.95% |
Dec 29, 2006 | 88.20M | -17.72% |
Dec 30, 2005 | 107.20M | 26.86% |
Dec 31, 2004 | 84.50M | -25.88% |
Dec 31, 2003 | 114.00M | 665.10% |
Dec 31, 2002 | 14.90M | -88.15% |
Dec 31, 2001 | 125.70M | 10.94% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 652.84B |
Johnson & Johnson | 429.72B |
AbbVie | 375.50B |
UnitedHealth Group | 285.64B |
AstraZeneca | 253.68B |
Novartis AG | 252.55B |
Novo Nordisk | 244.67B |
Abbott Laboratories | 231.38B |